Kantarjian, H., Thomas, D., Jorgensen, J., Kebriaei, P., Jabbour, E., Rytting, M., . . . O'Brien, S. (2013). Results of Inotuzumab Ozogamicin, a CD22 Monoclonal Antibody in Refractory and Relapsed Acute Lymphocytic Leukemia.
Citação norma ChicagoKantarjian, Hagop, et al. Results of Inotuzumab Ozogamicin, a CD22 Monoclonal Antibody in Refractory and Relapsed Acute Lymphocytic Leukemia. 2013.
MLA CitationKantarjian, Hagop, et al. Results of Inotuzumab Ozogamicin, a CD22 Monoclonal Antibody in Refractory and Relapsed Acute Lymphocytic Leukemia. 2013.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.